Clinical Characteristics, Prognosis and Prognostic Model of Pediatric Immune Thrombocytopenia: a Prospective, Multicenter, Observational Cohort Study
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
Immune thrombocytopenic purpura (ITP) is a kind of rare childhood disease that involve autoimmune destruction of platelets.The current Pediatric ITP cohorts are mostly based on single-center or multi-center cases, or cohorts with limited sample size in China. There is a lack of comprehensive and large-scale prospective cohort studies in pediatric ITP. The purpose of this study is to analyze the clinical characteristics of Pediatric ITP, the treatment methods, prognosis and prognostic model of these patients in China.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 17
View:
• Age 6-17 years old (including both ends), male and female;
• Diagnosis of ITP.
Locations
Other Locations
China
Chinese Academy of Medical Science and Blood Disease Hospital
RECRUITING
Tianjin
Contact Information
Primary
Ting Sun, MD
sunting@ihcams.ac.cn
02223909009
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2036-12
Participants
Target number of participants: 500
Treatments
Pediatric Primary Immune Thrombocytopenia
Immune thrombocytopenia (ITP) : defined according to the international working group criteria
Related Therapeutic Areas
Sponsors
Collaborators: The First Affiliated Hospital of Xiamen University, Beijing Children's Hospital, The Second Affiliated Hospital of Kunming Medical University, Henan Cancer Hospital, Tianjin People's Hospital, Tianjin Medical University Second Hospital
Leads: Institute of Hematology & Blood Diseases Hospital, China